IRW-News: Aleafia Health Inc.: Aleafia Health begrüßt

aleafia health stock tsx

aleafia health stock tsx - win

Aleafia Health Inc. (TSX:ALEF) Commences Trading on the Toronto Stock Exchange

Aleafia Health Inc. (TSX:ALEF) Commences Trading on the Toronto Stock Exchange submitted by WeedStocksCanada to CanadaWeedStocks [link] [comments]

Delta 9 ($DN) Most undervalued weed stock by far

Delta 9 (TSX:DN)(OTCQX:VRNDF) has been flying under the radar for some time. They just had a record volume day and I think are primed for takeoff. Their market cap is ~60 million and they did over 50 million in revenue last year!!! Most other weedstocks are valued way higher than this! Just to give you an idea here are some of the names I’ve been seeing lately as comparables...
Aleafia Health. Revenue last 4 Q’s ~ 35 million Market cap - 382 million (11x their revs)
WMD Revenue last 4 Q’s ~ 27 million Market cap - 197 million (7x their revs)
TGOD Revenue last 4 Q’s ~ 22 million Market cap - 287 million (13x their revs)
Delta 9 Revenue last 4 Q’s ~ 52 million Market cap - 60 million (1x their revs!)
As you can see they are valued at a massive discount compared to their peers. Some of the other numbers I have projected for their growth are even more convincing!
In Q3 for their retail business segment, they reported 8.6 million in revenue. This was for only 4 stores. They just opened their 10th store which means Q1 2021 could be around 20 million for retail sales alone! They have stated they plan to open 20 by the end of 2021 and they have followed through on all expansion plans so far so I have no reason to doubt it. That means Q1 2022 they could report 40 million or 160 million in annual retail revenue!!!!!
It doesn’t stop there because they have other business segments including Cultivation, Processing, and Wholesale and business to business (b2b) sales which is the sale of their grow pods to other cannabis companies . Both of these on average have added an extra ~ 3 million a quarter or 12 million a year. So that’s ~ 24 million a year combined assuming no growth. But as the US laws open up to allow more states to legalize, Delta 9 has announced plans to expand its B2B segment South of the border! So I expect there will at least be some growth here.
There is not much negative here. They have some debt as all growing cannabis companies do but are one of the few companies who has a line of credit at a reasonable rate with a major Canadian bank. I have seen people say the debentures are holding them back which could be a factor since Aleafia Health recently announced they intended to repay theirs in cash and the stock has run 140% since. However, this is not a concern in my mind as by my projections, Delta 9 will have ample cash to pay them off when they mature in 2022 and the cash is better used to expand their retail footprint. They had negative EBITDA last quarter but this was due to a one time write down, which we have seen other companies do as well unfortunately. The last two quarters before that they had positive EBITDA and I expect this upcoming quarter they will announce positive EBITDA as well.
Fully diluted they have about 130 million shares...insider ownership is approx 35% so there’s not a huge share float and high volume could really get this moving!
Forgot to mention their cost per gram is the best I’ve heard of in the industry (that’s counting all the major players) at $0.67! Even if it’s not the lowest that’s incredible for an indoor grow!
Right now I believe this is a $3 stock, which would only value them at 5x their current revenue, which is still conservative considering how much growth they will see over the next couple years.
Position: ~ 25,000 shares
TLDR: $DN is massively undervalued and should be 500% higher right now and 1000% higher in a year.
submitted by PayedShill to Canadapennystocks [link] [comments]

Delta 9 in most undervalued weed stock

Delta 9 (TSX:DN)(OTCQX:VRNDF) has been flying under the radar for some time. They just had a record volume day and I think are primed for takeoff. Their market cap is ~60 million and they did over 50 million in revenue last year!!! Most other weedstocks are valued way higher than this! Just to give you an idea here are some of the names I’ve been seeing lately as comparables...
Aleafia Health. Revenue last 4 Q’s ~ 35 million Market cap - 382 million (11x their revs)
WMD Revenue last 4 Q’s ~ 27 million Market cap - 197 million (7x their revs)
TGOD Revenue last 4 Q’s ~ 22 million Market cap - 287 million (13x their revs)
Delta 9 Revenue last 4 Q’s ~ 52 million Market cap - 60 million (1x their revs!)
As you can see they are valued at a massive discount compared to their peers. Some of the other numbers I have projected for their growth are even more convincing!
In Q3 for their retail business segment, they reported 8.6 million in revenue. This was for only 4 stores. They just opened their 10th store which means Q1 2021 could be around 20 million for retail sales alone! They have stated they plan to open 20 by the end of 2021 and they have followed through on all expansion plans so far so I have no reason to doubt it. That means Q1 2022 they could report 40 million or 160 million in annual retail revenue!!!!!
It doesn’t stop there because they have other business segments including Cultivation, Processing, and Wholesale and business to business (b2b) sales which is the sale of their grow pods to other cannabis companies . Both of these on average have added an extra ~ 3 million a quarter or 12 million a year. So that’s ~ 24 million a year combined assuming no growth. But as the US laws open up to allow more states to legalize, Delta 9 has announced plans to expand its B2B segment South of the border! So I expect there will at least be some growth here.
There is not much negative here. They have some debt as all growing cannabis companies do but are one of the few companies who has a line of credit at a reasonable rate with a major Canadian bank. I have seen people say the debentures are holding them back which could be a factor since Aleafia Health recently announced they intended to repay theirs in cash and the stock has run 140% since. However, this is not a concern in my mind as by my projections, Delta 9 will have ample cash to pay them off when they mature in 2022 and the cash is better used to expand their retail footprint. They had negative EBITDA last quarter but this was due to a one time write down, which we have seen other companies do as well unfortunately. The last two quarters before that they had positive EBITDA and I expect this upcoming quarter they will announce positive EBITDA as well.
Fully diluted they have about 130 million shares...insider ownership is approx 35% so there’s not a huge share float and high volume could really get this moving!
Forgot to mention their cost per gram is the best I’ve heard of in the industry (that’s counting all the major players) at $0.67! Even if it’s not the lowest that’s incredible for an indoor grow!
Right now I believe this is a $3 stock, which would only value them at 5x their current revenue, which is still conservative considering how much growth they will see over the next couple years.
Lurked here for the past couple years and would love to get the subs thoughts!
Position: ~ 25,000 shares
TLDR: Delta 9 ...the most undervalued weed stock around.
submitted by PayedShill to weedstocks [link] [comments]

Delta 9 is the most undervalued weed stock by far

Delta 9 (TSX:DN)(OTCQX:VRNDF) has been flying under the radar for some time. They just had a record volume day and I think are primed for takeoff. Their market cap is ~60 million and they did over 50 million in revenue last year!!! Most other weedstocks are valued way higher than this! Just to give you an idea here are some of the names I’ve been seeing lately as comparables...
Aleafia Health. Revenue last 4 Q’s ~ 35 million Market cap - 382 million (11x their revs)
WMD Revenue last 4 Q’s ~ 27 million Market cap - 197 million (7x their revs)
TGOD Revenue last 4 Q’s ~ 22 million Market cap - 287 million (13x their revs)
Delta 9 Revenue last 4 Q’s ~ 52 million Market cap - 60 million (1x their revs!)
As you can see they are valued at a massive discount compared to their peers. Some of the other numbers I have projected for their growth are even more convincing!
In Q3 for their retail business segment, they reported 8.6 million in revenue. This was for only 4 stores. They just opened their 10th store which means Q1 2021 could be around 20 million for retail sales alone! They have stated they plan to open 20 by the end of 2021 and they have followed through on all expansion plans so far so I have no reason to doubt it. That means Q1 2022 they could report 40 million or 160 million in annual retail revenue!!!!!
It doesn’t stop there because they have other business segments including Cultivation, Processing, and Wholesale and business to business (b2b) sales which is the sale of their grow pods to other cannabis companies . Both of these on average have added an extra ~ 3 million a quarter or 12 million a year. So that’s ~ 24 million a year combined assuming no growth. But as the US laws open up to allow more states to legalize, Delta 9 has announced plans to expand its B2B segment South of the border! So I expect there will at least be some growth here.
There is not much negative here. They have some debt as all growing cannabis companies do but are one of the few companies who has a line of credit at a reasonable rate with a major Canadian bank. I have seen people say the debentures are holding them back which could be a factor since Aleafia Health recently announced they intended to repay theirs in cash and the stock has run 140% since. However, this is not a concern in my mind as by my projections, Delta 9 will have ample cash to pay them off when they mature in 2022 and the cash is better used to expand their retail footprint. They had negative EBITDA last quarter but this was due to a one time write down, which we have seen other companies do as well unfortunately. The last two quarters before that they had positive EBITDA and I expect this upcoming quarter they will announce positive EBITDA as well.
Fully diluted they have about 130 million shares...insider ownership is approx 35% so there’s not a huge share float and high volume could really get this moving!
Forgot to mention their cost per gram is the best I’ve heard of in the industry (that’s counting all the major players) at $0.67! Even if it’s not the lowest that’s incredible for an indoor grow!
Right now I believe this is a $3 stock, which would only value them at 5x their current revenue, which is still conservative considering how much growth they will see over the next couple years.
Position: ~ 25,000 shares
TLDR: $DN is massively undervalued and should be 500% higher right now and 1000% higher in a year.
submitted by PayedShill to Baystreetbets [link] [comments]

WEED STOCK WITH NO INFLATION, DN.TO

Delta 9 (TSX:DN)(OTCQX:VRNDF) has been flying under the radar for some time. They just had a record volume day and I think are primed for takeoff. Their market cap is ~60 million and they did over 50 million in revenue last year!!! Most other weedstocks are valued way higher than this! Just to give you an idea here are some of the names I’ve been seeing lately as comparables...
Aleafia Health. Revenue last 4 Q’s ~ 35 million Market cap - 382 million (11x their revs)
WMD Revenue last 4 Q’s ~ 27 million Market cap - 197 million (7x their revs)
TGOD Revenue last 4 Q’s ~ 22 million Market cap - 287 million (13x their revs)
Delta 9 Revenue last 4 Q’s ~ 52 million Market cap - 60 million (1x their revs!)
As you can see they are valued at a massive discount compared to their peers. Some of the other numbers I have projected for their growth are even more convincing!
In Q3 for their retail business segment, they reported 8.6 million in revenue. This was for only 4 stores. They just opened their 10th store which means Q1 2021 could be around 20 million for retail sales alone! They have stated they plan to open 20 by the end of 2021 and they have followed through on all expansion plans so far so I have no reason to doubt it. That means Q1 2022 they could report 40 million or 160 million in annual retail revenue!!!!!
It doesn’t stop there because they have other business segments including Cultivation, Processing, and Wholesale and business to business (b2b) sales which is the sale of their grow pods to other cannabis companies . Both of these on average have added an extra ~ 3 million a quarter or 12 million a year. So that’s ~ 24 million a year combined assuming no growth. But as the US laws open up to allow more states to legalize, Delta 9 has announced plans to expand its B2B segment South of the border! So I expect there will at least be some growth here.
There is not much negative here. They have some debt as all growing cannabis companies do but are one of the few companies who has a line of credit at a reasonable rate with a major Canadian bank. I have seen people say the debentures are holding them back which could be a factor since Aleafia Health recently announced they intended to repay theirs in cash and the stock has run 140% since. However, this is not a concern in my mind as by my projections, Delta 9 will have ample cash to pay them off when they mature in 2022 and the cash is better used to expand their retail footprint. They had negative EBITDA last quarter but this was due to a one time write down, which we have seen other companies do as well unfortunately. The last two quarters before that they had positive EBITDA and I expect this upcoming quarter they will announce positive EBITDA as well.
Fully diluted they have about 130 million shares...insider ownership is approx 35% so there’s not a huge share float and high volume could really get this moving!
Forgot to mention their cost per gram is the best I’ve heard of in the industry (that’s counting all the major players) at $0.67! Even if it’s not the lowest that’s incredible for an indoor grow!
Right now I believe this is a $3 stock, which would only value them at 5x their current revenue, which is still conservative considering how much growth they will see over the next couple years.
Position: ~ 1000 shares
TLDR: $DN is massively undervalued and should be 500% higher right now and 1000% higher in a year.
(not my dd credit to u/PayedShill)
submitted by masutahentai to Wealthsimple_Penny [link] [comments]

Delta 9 in most undervalued weed stock

Delta 9 in most undervalued weed stock
Delta 9 (TSX:DN)(OTCQX:VRNDF) has been flying under the radar for some time. They just had a record volume day and I think are primed for takeoff. Their market cap is ~60 million and they did over 50 million in revenue last year!!! Most other weedstocks are valued way higher than this! Just to give you an idea here are some of the names I’ve been seeing lately as comparables...Aleafia Health. Revenue last 4 Q’s ~ 35 million Market cap - 382 million (11x their revs)WMD Revenue last 4 Q’s ~ 27 million Market cap - 197 million (7x their revs)TGOD Revenue last 4 Q’s ~ 22 million Market cap - 287 million (13x their revs)Delta 9 Revenue last 4 Q’s ~ 52 million Market cap - 60 million (1x their revs!)As you can see they are valued at a massive discount compared to their peers. Some of the other numbers I have projected for their growth are even more convincing!In Q3 for their retail business segment, they reported 8.6 million in revenue. This was for only 4 stores. They just opened their 10th store which means Q1 2021 could be around 20 million for retail sales alone! They have stated they plan to open 20 by the end of 2021 and they have followed through on all expansion plans so far so I have no reason to doubt it. That means Q1 2022 they could report 40 million or 160 million in annual retail revenue!!!!!It doesn’t stop there because they have other business segments including Cultivation, Processing, and Wholesale and business to business (b2b) sales which is the sale of their grow pods to other cannabis companies . Both of these on average have added an extra ~ 3 million a quarter or 12 million a year. So that’s ~ 24 million a year combined assuming no growth. But as the US laws open up to allow more states to legalize, Delta 9 has announced plans to expand its B2B segment South of the border! So I expect there will at least be some growth here.There is not much negative here. They have some debt as all growing cannabis companies do but are one of the few companies who has a line of credit at a reasonable rate with a major Canadian bank. I have seen people say the debentures are holding them back which could be a factor since Aleafia Health recently announced they intended to repay theirs in cash and the stock has run 140% since. However, this is not a concern in my mind as by my projections, Delta 9 will have ample cash to pay them off when they mature in 2022 and the cash is better used to expand their retail footprint. They had negative EBITDA last quarter but this was due to a one time write down, which we have seen other companies do as well unfortunately. The last two quarters before that they had positive EBITDA and I expect this upcoming quarter they will announce positive EBITDA as well.Fully diluted they have about 130 million shares...insider ownership is approx 35% so there’s not a huge share float and high volume could really get this moving!Forgot to mention their cost per gram is the best I’ve heard of in the industry (that’s counting all the major players) at $0.67! Even if it’s not the lowest that’s incredible for an indoor grow!Right now I believe this is a $3 stock, which would only value them at 5x their current revenue, which is still conservative considering how much growth they will see over the next couple years.Lurked here for the past couple years and would love to get the subs thoughts!Position: ~ 25,000 sharesTLDR: Delta 9 ...the most undervalued weed stock around.
Submitted February 11, 2021 at 11:33AM
submitted by weedislifeman to weedstocksreddit [link] [comments]

Delta 9 is the most undervalued weed stock

Delta 9 (TSX:DN)(OTCQX:VRNDF) has been flying under the radar for some time. They just had a record volume day and I think are primed for takeoff. Their market cap is ~60 million and they did over 50 million in revenue last year!!! Most other weedstocks are valued way higher than this! Just to give you an idea here are some of the names I’ve been seeing lately as comparables...
Aleafia Health. Revenue last 4 Q’s ~ 35 million Market cap - 382 million (11x their revs)
WMD Revenue last 4 Q’s ~ 27 million Market cap - 197 million (7x their revs)
TGOD Revenue last 4 Q’s ~ 22 million Market cap - 287 million (13x their revs)
Delta 9 Revenue last 4 Q’s ~ 52 million Market cap - 60 million (1x their revs!)
As you can see they are valued at a massive discount compared to their peers. Some of the other numbers I have projected for their growth are even more convincing!
In Q3 for their retail business segment, they reported 8.6 million in revenue. This was for only 4 stores. They just opened their 10th store which means Q1 2021 could be around 20 million for retail sales alone! They have stated they plan to open 20 by the end of 2021 and they have followed through on all expansion plans so far so I have no reason to doubt it. That means Q1 2022 they could report 40 million or 160 million in annual retail revenue!!!!!
It doesn’t stop there because they have other business segments including Cultivation, Processing, and Wholesale and business to business (b2b) sales which is the sale of their grow pods to other cannabis companies . Both of these on average have added an extra ~ 3 million a quarter or 12 million a year. So that’s ~ 24 million a year combined assuming no growth. But as the US laws open up to allow more states to legalize, Delta 9 has announced plans to expand its B2B segment South of the border! So I expect there will at least be some growth here.
There is not much negative here. They have some debt as all growing cannabis companies do but are one of the few companies who has a line of credit at a reasonable rate with a major Canadian bank. I have seen people say the debentures are holding them back which could be a factor since Aleafia Health recently announced they intended to repay theirs in cash and the stock has run 140% since. However, this is not a concern in my mind as by my projections, Delta 9 will have ample cash to pay them off when they mature in 2022 and the cash is better used to expand their retail footprint. They had negative EBITDA last quarter but this was due to a one time write down, which we have seen other companies do as well unfortunately. The last two quarters before that they had positive EBITDA and I expect this upcoming quarter they will announce positive EBITDA as well.
Fully diluted they have about 130 million shares...insider ownership is approx 35% so there’s not a huge share float and high volume could really get this moving!
Forgot to mention their cost per gram is the best I’ve heard of in the industry (that’s counting all the major players) at $0.67! Even if it’s not the lowest that’s incredible for an indoor grow!
Right now I believe this is a $3 stock, which would only value them at 5x their current revenue, which is still conservative considering how much growth they will see over the next couple years.
Position: ~ 25,000 shares
TLDR: $DN is massively undervalued and should be 500% higher right now and 1000% higher in a year.
submitted by PayedShill to Baystreetbets [link] [comments]

CANNABIS STOCKS OPPORTUNITY

CANNABIS STOCKS OPPORTUNITY
Canadian Cannabis Industry stocks look like they turned the corner on proving their profitability & viability & are ready to go back up to their full potentials.
Adult Recreational Sales of Cannabis 2.0 have gone up due to hoarding like toilet paper & sales will keep growing during self isolation rules in Canada.
Cannabis 2.0 & derivatives are legal in Canada & the government is the biggest distributor & they also retail too. You can buy it online, at a store or get it delivered. They definitely will be expanding Cannabis Sales for taxes for all the Covid19 Aid & Cash they are giving to citizens & businesses.
Here's the Canadian Cannabis Stocks trading on the TSX, USA (NYSE & Nasdaq) & some European exchanges:
  • Aurora Cannabis Inc (ACB)
  • Aphria Inc. (APHA)
  • Canopy Growth Corporation (CGC / WEED)
  • Cronos Group Inc (CRON)
  • HEXO Corp (HEXO)
  • OrganiGram Holdings Inc. (OGI)
  • Tilray Inc (TLRY - not on TSX)
  • Village Farms International, Inc. (VFF)
They all are near their 52 week lows & are Short Squeeze candidates. ACB popped a bit since their last Q3 May 14 ER but there's still lots of room to go up. HEXO is next on June 11.
They're stocks are all very volatile right now because they just turned the corner & should reach their full potential again but they've been heavily shorted for the past year.
Investors must think ACB is the leader of the Cannabis Industry because when it's stock makes large moves, up or down, it pulls the rest with it.
During the Industry Shakeout Stage, there will be lots of M&A & buyouts, so buckle up your seat belts because the wild ride is not over yet.
Past Big Stock Pick winners that I posted about in the past before their run up:
AMD, ATVI, BABA, FB, GOOG, LOGI, LULU, MU, NVDA, PYPL, STX, TSLA, TWTR
Good luck & always do your Due Diligence before investing.
UPDATE Recently Added Stocks trading on TSX & OTC:
  • Aleafia Health Inc. (AH)
  • Charlotte's Web Holdings, Inc. (CWEB)
  • Fire & Flower Holdings Corp. (FAF)
  • The Supreme Cannabis Company, Inc. (FIRE)
  • MediPharm Labs Corp. (LABS)
  • The Green Organic Dutchman Holdings Ltd. (TGOD)
  • Neptune Wellness Solutions Inc. (NEPT)
  • VIVO Cannabis Inc. (VIVO)
  • Zenabis Global Inc. (ZENA)
For those that want to get into a more safer Cannabis Industry investment, this is it. It also pays a nice quarterly dividend from lending out their shares for short selling.
Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ)
Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ)
Diversified exposure: Unlike an investment in the stock of a single Marijuana company, HMMJ provides exposure to a diversified group of companies within the industry, reducing single security risk (although an ETF provides diversification, it may also limit the upside potential of owning an individual stock)
• Rebalanced quarterly: The Marijuana industry is rapidly growing and evolving. Quarterly rebalances seek to ensure the composition of HMMJ reflects the changing leadership and drivers of growth within the industry
More HMMJ Due Diligence:
https://www.reddit.com/CanadianInvestocomments/gwilgy/1415_dividend_yield_horizons_marijuana_life
_______________________________
What the Ancients Knew: A Sacred Plant Used for Hundreds of Conditions (July 31, 2019):
Cannabis, an Ancient Sacred Plant, is totally natural, has no dangerous side effects when used properly, and is chock-full of hundreds of healing phytonutrients, including antioxidants.
In fact, ancient healing systems such as Ayurveda and Traditional Chinese Medicine referenced Cannabis in their texts as far back as 2600 BC.
https://thetruthaboutcancer.com/benefits-of-cannabis
Medical Marijuana for Post-Traumatic Stress Disorder (PTSD):
https://www.marijuanadoctors.com/conditions/post-traumatic-stress-disorder-ptsd
Canada’s Aurora Cannabis (ACB) surges after hours making a CBD deal to enter the lucrative U.S. market (May 20, 2020):
Aurora Cannabis to Strategically Enter the United States with Acquisition of Reliva, LLC A Market Leading Mass Retail CBD Platform
https://www.prnewswire.com/news-releases/aurora-cannabis-to-strategically-enter-the-united-states-with-acquisition-of-reliva-llc-a-market-leading-mass-retail-cbd-platform-301063067.html
CBD global market growing at CAGR of 32.0% over 5 years to US$1.252 Billion in 2024 (April 20, 2020):
https://www.globenewswire.com/news-release/2020/04/20/2018808/0/en/CBD-Oil-Market-Size-2020-Industry-Share-Growth-Trends-Revenue-Analysis-Top-Leaders-Dr-Hemp-Me-Green-Roads-Royal-CBD-CBD-Oil-Europe-King-CBD-Says-DBMR-Analyst.html
​
Heavily Shorted Cannabis Stocks = Short Squeeze Candidates
_______________________________
The Marijuana Industry Is in Recovery. Curaleaf’s Chairman Is Upbeat (May 19, 2020):
Pot producers have done better than many businesses during the Covid-19 crisis, with American operators growing sales by some 30% sequentially in the March quarter. Even so, you can count the industry as among the economy’s recovery plays when humans come out from hiding.
https://www.barrons.com/articles/curaleafs-ceo-is-upbeat-on-outlook-for-sales-of-marijuana-51589915574
_______________________________
Aurora Cannabis shares skyrocket on hopes worst is behind Canadian weed company (May 19, 2020):
According to Ladenburg Thalmann analyst Glenn Mattson, as quoted by MarketWatch, Aurora has made strides in its reorganization plan announced in February. "We think ACB can become a solid cash-flow generator simply from the Canadian operations and, with a strong market position in Canada, the company can create significant value from here based on this one market," Mattson wrote in a note to clients. "We do think that it will look to expand into the U.S. but not until federal legality is more clear."
South Korea’s sovereign-wealth fund disclosed Monday that it had acquired a chunk of Aurora stock. Switzerland’s central bank also recently boosted its Aurora holdings.
https://www.marketwatch.com/story/aurora-cannabis-shares-skyrocket-on-hopes-worst-is-behind-canadian-weed-company-2020-05-18
_______________________________
Potential USA Federal Legalization
U.S. cannabis companies say legalization would be an economic savior (April 27, 2020):
Cannabis is a revenue generator — and therefore, a tax generator, adds Boris Jordan, executive chairman for U.S.-based Curaleaf. “One of the programs by the federal government right after the Great Depression was to focus on tax revenue generation,” Jordan tells CNBC. “They lifted prohibition on alcohol and therefore started to tax it — and it became a major revenue generator for both the federal and the local governments around the country.”
https://www.thegrowthop.com/cannabis-news/covid-19-usa-canada-weed-economy
_______________________________
Governments earned $186M in pot taxes in 5.5 months of legalization on Oct 17, 2018: StatsCan (Jun 19, 2019):
“My approach is to make sure that the taxation of cannabis is consistent with the goal of keeping cannabis out of the hands of kids and out of the black market,” federal Finance Minister Bill Morneau told the House of Commons last February [2019]. “That means keeping the taxes low so we can actually get rid of the criminals in the system.”
They've made a lot of progress. Everyone will prefer the competitively priced Cannabis 2.0 products over the black market stuff. They're all sealed with ingredient & THC & CBD strength. Drug Dealers are Covid19 Super Spreaders. I'll stick to government sealed & certified stuff. After all, they're helping everyone, so I'll help me, help us through more taxes. ;)
Honestly, all the unlicensed producers & retailers have been shut down due to even more potential fines & even criminal charges due to Covid19 Rules, while legal ones are all open as "essential" businesses.
https://www.bnnbloomberg.ca/governments-earned-186m-in-pot-taxes-in-5-5-months-of-legalization-statscan-1.1275554
_______________________________
Everything you should know about legal weed in Canada (including how to get it)
And why you might (or might not) want a prescription.
Some insurers cover the costs of prescription cannabis, but most don’t. Come tax time, prescription cannabis costs are considered an eligible medical expense, so you’ll be able to claim them on your tax return.
https://www.theloop.ca/get-legal-cannabis-prescription
_______________________________
Hemp Biofuel Could Ease Our Dependence On Fossil Fuels (Oct 25, 2019):
The cannabis plant is the gift that keeps on giving. This magic plant gives us CBD oil, THC, hemp fibers and even fuel! Researchers have made hemp into two types of biofuel: biodiesel and ethanol.
https://ministryofhemp.com/blog/hemp-biofuel
_______________________________

Study: Cannabis Could Prevent COVID-19 Infections (May 16, 2020):

There's lots of potential with Tobacco & Alcohol cross-over products. There will be deals with Biotech too, if not already. Possibly even in clean energy too with Hemp Biofuel.
There's even some word about a possible Covid19 Vaccine or preventative products based on Cannabis.
Novel combinations of cannabinoids “may become a useful addition to the treatment of COVID-19,” the researchers wrote. “They may also be used to develop additional easy-to-use preventative strategies such as mouth wash and throat gargle products that may be tested for their potential to decrease viral entry via the oral cavity and may be used both in clinical practice and at-home treatment.”
In experiments with 3D human cell cultures mimicking various diseases, certain high CBD cannabis strains—developed by the researchers labs, in no relation to the cannabis available in legal and recreational markets in Canada or the US—demonstrated abilities to shut down coronavirus’s favorite “pathway: a receptor called ACE2.
“Our work could have a huge influence — there aren’t many drugs that have the potential of reducing infection by 70 to 80 per cent”.
At the University of Lethbridge, Drs. Igor and Olga Kovalchuk, of the Plant Biotechnology Laboratory, are studying how medical cannabis cultivars helps combat symptoms of the COVID-19 virus.
https://www.benzinga.com/markets/cannabis/20/05/16046911/study-cannabis-could-prevent-covid-19-infections
_______________________________
Quarantined Americans embrace cannabis, reshaping an industry (May 22, 2020):
A lot of the increase has come from regular users, especially millennials, Brightfield’s data show. Among people who’ve used cannabis in the last year, 34 per cent said in late March that they’re using it more frequently, and 16 per cent say they’re using higher doses or doing longer sessions.
For millennials, those numbers are higher: 41 per cent use more frequently, and 20 per cent use higher doses.
Not all the increase in sales is for recreational use. Curaleaf said it’s also witnessed an increase in patients and older clientele.
“A lot of the users coming into the sector now are people who never used before,” said Curaleaf’s Jordan. Many of them are over 60 “and asking for pain relief, sleep aids, anxiety relief -- and it’s mostly not smokable.”

“Think about where cannabis was a few years ago -- illegal,” said Chris Melillo, Curaleaf’s senior vice president of retail. “And now we’re essential.”

https://www.bnnbloomberg.ca/quarantined-americans-embrace-cannabis-reshaping-an-industry-1.1439872
_______________________________
Aurora Cannabis: Blossoming Opportunity in a Battered Industry (May 21, 2020)
The dot-com bubble almost two decades ago inflicted painful stock losses on historically bullish investors. Mega-caps like Apple saw its equity crash, only to later grow far beyond once expensive valuations. New products were in inning one of a fruitful road to ubiquity. I believe a similar opportunity is materializing in the cannabis sector today.
https://www.fool.com/investing/2020/05/21/aurora-cannabis-historic-opportunity-in-a-battered.aspx
_______________________________
Cannabis Stocks Surge on Report of Benefits in Fighting Covid-19 (Update: May 22, 2020)
Some strains of medical marijuana said to block coronavirus pathways into cells.
https://www.thestreet.com/investing/cannabis-stocks-surge-on-report-of-benefits-in-fighting-covid-19
_______________________________
Cannabis Canada: Pot generates $8.16B toward Canada's economy, StatsCan says (Apr 30, 2020)
Canada's cannabis industry generates about $8.16 billion to the country's economy, according to latest data from Statistics Canada. The legal cannabis industry contributed about $3.96 billion to Canada's gross domestic product as of February, StatsCan said. That's up 215 per cent since recreational cannabis was legalized in Oct. 2018. Meanwhile, StatsCan said the illicit market is estimated to contribute $4.13 billion to the country's economy. That's down about 21 per cent since Oct. 2018.
https://www.bnnbloomberg.ca/cannabis-canada-pot-generates-8-16b-toward-canada-s-economy-statscan-says-1.1429717
_______________________________
Why Village Farms Stock Crushed It Today (May 22, 2020)
Shares of Village Farms International (NASDAQ: VFF) were soaring 22.6% as of 3:50 p.m. EDT on Friday. The cannabis and greenhouse produce company didn't announce any news of its own, but there were several other developments that were likely behind Village Farms' big gain.
One potential factor for the Village Farms' jump was Statistics Canada's release Friday morning of data showing that cannabis sales in Canada skyrocketed in March. Also, results from a study were announced on Thursday that found that some cannabis strains could help prevent the novel coronavirus from entering host cells. In addition, Bank of America reinstated coverage on big cannabis producer Canopy Growth (NYSE: CGC) with a buy rating, which could be viewed as a positive sign for the entire Canadian cannabis industry.
https://www.nasdaq.com/articles/why-village-farms-stock-crushed-it-today-2020-05-22
_______________________________
NY Gov. Cuomo Says He'll Work To Pass Cannabis Legalization: 'It's A Complicated Issue' (May 26, 2020)
New York Gov. Andrew Cuomo has announced intention to enact cannabis legalization in the near future.
“I believe we will, but we didn't get it done this last session because it's a complicated issue and it has to be done in a comprehensive way, ” Cuomo said during a Friday press conference.
Cuomo also said it was the federal government's obligation to financially aid the city at this time. Just as the airline and hotel industries are getting assistance, so should the city's health care workers, he said.
Cuomo added that he was in favor of marijuana legalization and affirmed that he had worked arduously to pass that into law for years, but ultimately without success.
https://www.benzinga.com/markets/cannabis/20/05/16097973/ny-gov-cuomo-says-hell-work-to-pass-cannabis-legalization-its-a-complicated-issue

May 26, 2020: Comparing Canada’s 17th month of recreational cannabis sales with Colorado's figures indicates that the country’s market may grow to CA$14 BILLION ($10.16B) by the end of 2024, Zuanic said in the industry note.

https://www.benzinga.com/analyst-ratings/analyst-colo20/05/16106548/aphria-aurora-among-top-performers-as-canadian-cannabis-sales-spike

Oregon sees record breaking $89M in Marijuana Sales in April for the second-straight month, Oregon broke sales records for legal marijuana. (May 27, 2020)

https://www.kgw.com/article/news/health/coronavirus/oregon-sees-record-breaking-89-million-in-marijuana-sales-for-april/283-fae5cbc4-0d25-4936-b749-bf049a408270

Aphria (APHA) Shoots 4.5% Higher on News of Move to Nasdaq (May 27, 2020)

Aphria said that one of the main reasons for the move was to save money. Listing on the NYSE, considered a prestige exchange, can be very costly, and like many other marijuana companies Aphria has at times struggled with profitability. The company also said the Nasdaq was a better fit given that exchange's emphasis on environmental, social, and governmental (ESG) principles.
ACB & HEXO should do the same imo.
https://www.nasdaq.com/articles/aphria-shoots-4.5-higher-on-news-of-move-to-nasdaq-2020-05-27
submitted by extriniti to wallstreetbets [link] [comments]

Ticker symbol change?

$ALEF to $AH Anybody have any thoughts on why the company change the ticker symbol. What benefits to changing a ticker symbol give a company.
TORONTO, May 27, 2020 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) announced that effective today, in connection with the previously announced bought deal financing, the Company’s common shares will trade on the Toronto Stock Exchange under the ticker symbol “AH”. The new ticker symbols for the Company’s securities are as follows:
Common shares: “AH”
8.5% unsecured convertible debentures: “AH.DB”
Common share purchase warrants: “AH.WT”
https://www.globenewswire.com/news-release/2020/05/27/2039477/0/en/Aleafia-Health-Announces-TSX-Ticker-Symbol-Change-to-AH.html
submitted by RadMoney1 to aleafia [link] [comments]

Emblem Oil Products Update ALL OIL PRODUCTS NOW IN STOCK Hi Nicholas, At Aleafia Health, we are committe

Emblem Oil Products Update
ALL OIL PRODUCTS NOW IN STOCK
Hi Nicholas,
https://share.icloud.com/photos/0D31zyTfbx0r1JvXpvkxtCm_w
At Aleafia Health, we are committed to creating exceptional cannabis consumer experiences for each and every one of our valued patients. We strive to ensure we are always well positioned to supply our patients with the highest quality medical cannabis products.
We are pleased to confirm in-stock status for all oil products at levels to support continued availability during increased market demand. SHOP OIL PRODUCTS NOW Starting April 7th, some of our Emblem Balanced Oil products will be undergoing a minor name update to more accurately reflect the existing product formulation.
https://share.icloud.com/photos/0avQpwp__0nyLuCgldMuunIHQ
SUMMARY OF BALANCED OIL PRODUCT UPDATE
Current Product Name Updated Product Name
Emblem Oil - CBD 20 THC 12 Emblem Oil - CBD 20 THC 10 Emblem Atmosphere - CBD 20 THC 12 Emblem Atmosphere CBD 20 THC 10 Emblem Capsules - CBD 10 THC 6 Emblem Capsules - CBD 10 THC 5 Emblem Capsules - CBD 5 THC 3 Emblem Capsules - CBD 5 THC 2.5
PLEASE NOTE: The formulation of these products has not changed. Both the input material and target concentrations have remained the same, so this product name update will not impact your existing treatment plan.
You will see changes as a result of this name update rolling out gradually over the coming weeks, starting on April 7th, 2020.
​​​​​​We continue to offer Emblem Medical cannabis oils that are full spectrum, odourless, flavour-neutral, and strain-specific, creating a consistent experience for medical patients. Atmosphere Oral Spray Bottle EMBLEM OILS
These easy to use, discrete, odourless, taste-free and non-smoking formats make cannabis oils an excellent choice for many medical cannabis patients.
SHOP OILS We're here for you. As always, if you have any questions or feedback on any of our products or if you just need some help with your order, contact our Client Care Team at 1-844-546-3633 or [email protected].
https://share.icloud.com/photos/08tWvIEFxc9ftq4vORHVEfy8g
Did You Know?
You are a Registered Patient of Emblem Cannabis Corporate (ECC) a Division of Aleafia Health Inc. Aleafia Health (TSX: ALEF, OTC: ALEAF) is an industry leading, vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis. To learn more click here.
submitted by Urby81 to aleafia [link] [comments]

Midas Letter with Benjamin Ferdinand

Here's the direct link to the 'interview'.
Just a little excerpt to give you a flavour for the interrogator's penetrating interviewing skills. This fellow cuts right to core issues.
2:44
Q? "Well I can ask you a little bit about your company. I mean, you know, this must have been a big day for you guys in the office, you were celebrating, you were celebrating with, did you have cake and things, what is a company, I don't know what, did you have everyone come into the lunch room, somebody went out for muffins? What is it?"
~
Anyway...This interview helped to continue to expose Aleafia to the investment community (which is the only reason to do these types of interviews, really). Otherwise it was pretty empty. However, there was one thing that echoed for me.
1:55
Q. "What is the upside of being on the TSX?"
A. "So what it really allows you to do is have access to a lot more institutional investors...and when we get close to the billion dollar range, that's when we start to become more attractive for those types of investors".
~
Just a reminder, Benjamin Ferdinand was hired on at Aleafia on August 20th 2018 in the role of CFO. He comes "from TMX Group ("TMX"), the parent company of the Toronto Stock Exchange, where he led TMX's firmwide platform initiatives as Managing Director, Platform Strategies. Previously, Benjamin served as Vice-President and Head of Finance, Strategy and Corporate Development for TMX."
submitted by IvanSkavar to aleafia [link] [comments]

aleafia health stock tsx video

TSX (The Toronto Stock Exchange)Yes: Common Shares: CA: CAD: Mar 2018: ALEA.F: OTCPK (Pink Sheets LLC)Yes: Common Shares: US: USD: Mar 2018: ARAH: DB (Deutsche Boerse AG)Yes: Common Shares: DE: EUR: Mar 2018: Biography. Aleafia Health Inc. operates as an integrated cannabis health and wellness company. It produces a portfolio of products, including dried flower and pre-rolls, as well as oil TSX Venture Exchange Issuer Resources. TSX Venture Exchange Issuer Resources; TSX Venture Exchange Corporate Finance Manual; Publications; NEX; Info TSX Venture ; TSX Venture Exchange Market Information; Graduation to Toronto Stock Exchange; S&P/TSX Venture Index Eligibility; Third Party Contacts; Advisory Committees; Learning Academy; ESG 101; C-Suite at The Open; Contact Us; Current Market In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelic Stock News stories for the week of March 16th – 22nd, 2020.... read more → March 22, 2020; Ryan T. Demand For Psychedelic Investments Continues to Grow, New IPO Slated for 2020. Move Over Cannabis, Psychedelics Could Become the New Go-To Alternative Investment in 2020 New Psychedelic Firms Are Get the latest stock price for Aleafia Health Inc. (AH), plus the latest news, recent trades, charting, insider activity, and analyst ratings. Technical analysis gauges display real-time ratings for the selected timeframes. The summary for ALEAFIA HEALTH INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. Results are available at a quick glance. Aleafia Health has been named the TMX Group’s 2019 TSX Venture 50 top performing company of the year amongst all 2,000 TSX Venture Exchange listed companies. The award was based on three equally weighted criteria, market capitalization growth, share price appreciated and trading volume. This is the first time a cannabis company has achieved top performing status. Honours Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (Aleafia Health oder das Unternehmen) hat heute die größte Bestellung von Cannabis zur Anwendung durch Erwachsene (die Bestellung) in der Geschichte des Unternehmens verzeichnet. Die Bestellung soll heute die Anlage des Unternehmens verlassen und an eine kanadische Provinzregierung für den Vertrieb an Online- und Einzelhandelskunden 11.11.2020 - TORONTO, Nov. 11, 2020 (GLOBE NEWSWIRE) - Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to report its financial results for the Aleafia Health Repays $25M Debt with Cash, Provides Update on Sales Growth, New Product Mix. TORONTO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced the full repayment in cash of its 8% unsecured convertible debt (the “Convertible Debt”), which matured on February 2, 2021. Aleafia Health is a patient-focused healthcare solution. View our Investor Presentation & learn about Aleafia Health listed on the Toronto Stock Exchange, TSX.

aleafia health stock tsx top

[index] [5389] [8823] [4657] [2372] [6602] [4311] [6979] [5277] [3430] [7940]

aleafia health stock tsx

Copyright © 2024 top100.topkasino.fun